Sort
21,281 grants matching “influenza”
A multimodal platform for Oral screening of COVID-19
$500,000Roya Khosravi-Far · Innotech Precision Medicine, Inc · R42 · FY2022 · DE
Vaccine and Treatment Evaluation Units
$500,000Lisa A Jackson · Kaiser Foundation Health Plan Of Washington · N01 · FY2011 · AI
Identification and Development of Novel Influenza M2 Inhibitors
$500,000Benjamin Jacob Doranz · Integral Molecular · U01 · FY2009 · AI
VACCINE AND TREATMENT EVALUATION UNITS
$500,000Lisa A Jackson · Kaiser Foundation Health Plan Of Washington · N01 · FY2012 · AI
Vaccine and Treatment Evaluation Units
$500,000Lisa A Jackson · Kaiser Foundation Health Plan Of Washington · N01 · FY2012 · AI
VACCINE AND TREATMENT EVALUATION UNITS
$500,000Kathryn Margaret Edwards · Vanderbilt University · N01 · FY2012 · AI
VACCINE AND TREATMENT EVALUATION UNITS
$500,000Kathryn Margaret Edwards · Vanderbilt University · N01 · FY2012 · AI
The VAX-MOM study: Increasing Influenza and Tdap Vaccinations of Pregnant Women
$499,999Cynthia M Rand · University Of Rochester · U01 · FY2021 · IP
The VAX-MOM study: Increasing Influenza and Tdap Vaccinations of Pregnant Women
$499,999Cynthia M Rand · University Of Rochester · U01 · FY2020 · IP
The VAX-MOM study: Increasing Influenza and Tdap Vaccinations of Pregnant Women
$499,999Cynthia M Rand · University Of Rochester · U01 · FY2019 · IP
Impact of pre-existing SARS-CoV-2 immunity on vaccination against new variants
$499,999Sean D Sullivan · University Of Washington · P51 · FY2021 · OD
US Hospital Vaccine Effectiveness (VE) Network
$499,999Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2019 · IP
A randomized trial of influenza vaccination of Hutterite children
$499,999Mark Loeb · Mcmaster University · U01 · FY2008 · AI
Surveillance and Response to Avian and Pandemic Influenza by the National
$499,990Ilesh Jani · Instituto Nacional De Saude · U51 · FY2015 · IP
Washington National Primate Research Center
$499,987David M Anderson · University Of Washington · P51 · FY2014 · OD
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORK IN VIETNAM
$499,980Nguyen Tran Hien · National Institute Hygiene/Epidemiology · U50 · FY2006 · CI
Rural Trial of Clinic Order Entry with Decision Support
$499,962Matthew H Samore · University Of Utah · R01 · FY2006 · HS
BD LSR II Special Order System
$499,961Kenneth Michael Pollard · Scripps Research Institute, The · S10 · FY2010 · RR
Trusted School Messengers Promoting Non-Mandated Vaccination
$499,952Cynthia M Rand · University Of Rochester · U48 · FY2025 · DP
BREATHE WELL: Development and Implementation of a Training Program to Increase Vaccination in Early Childcare and Education Centers
$499,950Abram Luther Wagner · University Of Michigan At Ann Arbor · U48 · FY2025 · DP
INFLUENZA A VIRUS OF SWINE (IAV-S) IS WIDESPREAD IN THE SWINE POPULATION AND CAN CAUSE SIGNIFICANT ECONOMIC LOSS TO SWINE PRODUCERS. IAV-S VACCINES HAVE BEEN COMMONLY USED FOR CONTROL OF IAV-S IN THE US. UNFORTUNATELY THE EFFICACY OF THE CURRENTLY AVAILABLE VACCINES IS FAR FROM SATISFACTORY. THE MAIN LIMITATION IS THE THAT CURRENT VACCINES DO NOT CONFER ADEQUATE LEVELS OF PROTECTION DUE TO THE SUBSTANTIAL GENETIC DIVERSITY OF IAV-S CIRCULATING IN THE FIELD. THE ULTIMATE GOAL OF THIS PROPOSED RESEARCH IS TO DEVELOP A NOVEL VACCINE AGAINST IAV-S THAT WOULD ELICIT THE BROADEST LEVEL OF PROTECTION.WE WILL PURSUE A TWO-PRONGED APPROACH TO ACHIEVE THIS GOAL. FIRST WE WILL EMPLOY COMPUTATIONAL METHODS TO RATIONALLY DESIGN CONSENSUS IAV-S HEMAGGLUTININ (HA) IMMUNOGENS WITH THE BROADEST ANTIGENIC COVERAGE FOR THE IAV-S CIRCULATING IN THE US. SECOND WE WILL USE A NOVEL TRI-SEGMENTED PICHINDE VIRUS PICV-BASED VIRAL VECTOR TO DELIVER THE CONSENSUS HA IMMUNOGENS IN VACCINATED PIGS. ONE OF THE ADVANTAGES OF THIS PICV VIRAL VECTOR IS THAT IT SPECIFICALLY DELIVERS THE TARGET IMMUNOGENS TO DENDRITIC CELLS (DCS) AND MACROPHAGES OWING TO IS ABILITY TO REPLICATE IN THESE TWO CELL TYPES.OUR WORKINGHYPOTHESISIS PIGS VACCINATED WITH THE RECOMBINANT PICV-VIRAL VECTOR EXPRESSING THE CONSENSUS HA IMMUNOGENS WILL DEVELOP ROBUST LEVELS OF BROADLY PROTECTIVE IMMUNITY THAT WILL PROTECT THEM AGAINST DIVERGENT IAV-S STRAINS.SUCCESSFUL COMPLETION OF THIS PROJECT WILL SWINE PRODUCERS WITH AN EFFECTIVE TOOL TO REDUCE THE POTENTIAL ECONOMIC IMPACT OF IAV-S THEREBY ENHANCING THE SUSTAINABILITY AND COMPETITIVE ADVANTAGE OF THE US SWINE INDUSTRY.
$499,946Board Of Regents Of The University Of Nebraska · · FY2020 · National Institute of Food and Agriculture
Influence of polysialic acid on leukocyte migration
$499,945Nicholas Milton Stamatos · University Of Maryland Baltimore · R01 · FY2022 · AI
PEPTIDE NANOPARTICLES AS NOVEL IMMUNOGENS: DESIGN AND ANALYSIS OF AVIAN INFLUENZA VACCINE
$499,943University Of Connecticut · · FY2012 · National Institute of Food and Agriculture
SBIR Phase II: Portable BioDetection Platform for Rapid Identification of Multiple Biological Agents
$499,911Ihab A Abdel-Hamid · Mesosystems Technology, Inc. · · FY2004 · TIP
Pandemic Potential of H5N1 Influenza Viruses
$499,900Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2009 · AI